• LONDON, May 10- Britain is ready for "hard negotiation" to ensure Pfizer sticks to specific promises on jobs and science under the U.S. drugmaker's proposed takeover of AstraZeneca, its finance minister said. "I think it would be extraordinary not to engage with AstraZeneca or Pfizer," George Osborne told BBC radio on Saturday.

  • May 9- A former executive at an e-commerce company that was acquired in 2011 by online retailer eBay Inc pleaded guilty on Friday to insider trading in connection with the takeover. District Judge Stewart Dalzell in Philadelphia, and was released on $300,000 bail, court records show.

  • Max Wolff, Citizen V.C. chief economist; Yukari Kane, author of "Haunted Empire: Apple After Steve Jobs"; and David Nelson, Belpointe Asset Management.

  • Beats could be biggest Apple buy     Friday, 9 May 2014 | 3:26 PM ET

    A look at Apple's could-be deal with Beats Electronics, with CNBC's Morgan Brennan.

  • Hip hop millionaires     Friday, 9 May 2014 | 2:52 PM ET

    CNBC's Robert Frank reports on the race to be hip hop's first billionaire.

  • Songza CEO says industry 'young'     Friday, 9 May 2014 | 2:48 PM ET

    Discussing competition in the music streaming space, and what a potential deal between Apple and Beats Electronics could mean for the industry, with Elias Roman, Songza co-founder & CEO.

  • Potential Apple-Beats deal     Friday, 9 May 2014 | 1:19 PM ET

    CNBC has learned Apple is in talks to buy headphone maker Beats Electronics for $3.2 billion. CNBC contributor Natalie Morris, and Peter Kafka, Re/code senior editor, discuss.

  • What's the point of Apple/Beat deal?     Friday, 9 May 2014 | 8:31 AM ET

    It's a huge departure for Tim Cook, says Matthew Garrahan, Financial Times media editor, discussing Apple's rumored attempt to acquire Beat Electronics for $3.2 billion.

  • LONDON, May 9- The British government needs to be confident that any commitments made by Pfizer in a proposed takeover of AstraZeneca are binding, British Deputy Prime Minister Nick Clegg said on Friday.

  • May 8- The governors of Maryland and Delaware on Thursday sent a letter to Pfizer Inc Chief Executive Officer Ian Read "expressing deep concerns" about the pharmaceutical company's bid to acquire London- based AstraZeneca Plc.

  • *Two production JVs and research centre planned in China. GENOA, Italy, May 8- Shanghai Electric Group has agreed to pay 400 million euros for 40 percent of power engineering company Ansaldo Energia, becoming the latest Chinese company to buy into Italy's fledgeling economic recovery.

  • WASHINGTON, May 8- Lawmakers expressed concern about combining the top two U.S. cable operators at a congressional hearing Thursday to discuss Comcast's plan to merge with Time Warner Cable Inc..

  • LONDON, May 8- The European Commission would probably block any attempt by the British government to intervene in Pfizer's proposed takeover of AstraZeneca as Brussels itself would rule on a deal of that size, competition lawyers say. AstraZeneca has rejected the $106 billion bid to create the world's largest pharmaceuticals business.

  • May 8- Deal-making drugmaker Valeant Pharmaceuticals International Inc, together with activist investor Pershing Square, plan to push for changes on the board of Allergan Inc, which Valeant hopes to acquire.

  • BUSINESS-NEWS-SCHEDULE AT 1830 GMT / 2:30 PM ET Wednesday, 7 May 2014 | 2:42 PM ET

    British PM tells Pfizer wants more commitments for AstraZeneca deal. LONDON- Prime Minister David Cameron says Britain wants more commitments from Pfizer on its $106 billion takeover bid for British pharmaceutical company AstraZeneca.

  • *Cameron hints Britain could intervene in takeover deal. LONDON, May 7- Prime Minister David Cameron demanded U.S. drugmaker Pfizer give stronger guarantees it will keep jobs and investment in Britain in order to secure his government's blessing for a takeover of AstraZeneca.

  • Pfizer says AstraZeneca takeover would benefit science Wednesday, 7 May 2014 | 3:54 AM ET

    LONDON, May 7- Pfizer sought to allay fears that its proposed $106 billion takeover of AstraZeneca would deal a blow to drug research, saying the new company would bolster innovative science and speed the development of new treatments. AstraZeneca, Britain's second-largest drugs company, has rejected successive approaches from its larger American rival.

  • *UK could use public interest powers, Business Secretary says. *Lawmakers summon Pfizer, AstraZeneca bosses over takeover bid. LONDON, May 6- Britain could use its public interest powers to intervene in U.S. drugmaker Pfizer's $106- billion takeover bid for British pharmaceutical firm AstraZeneca, Business Secretary Vince Cable said on Tuesday.

  • LONDON, May 6- AstraZeneca Plc laid out its defence against Pfizer Inc's $106- billion takeover approach on Tuesday by predicting its sales would rise by three quarters over the next decade, although only after a short-term drop. "These are benefits that should fully accrue to AstraZeneca's shareholders."

  • LONDON, May 6- British lawmakers on Tuesday summoned bosses of U.S. drugmaker Pfizer to explain a $106 billion takeover bid for pharmaceutical firm AstraZeneca which has raised fears over UK jobs, research and intellectual property.